Trial Profile
The WE Study - Walking Easier with cerebral palsy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2023
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Muscle spasticity
- Focus Therapeutic Use
- Acronyms WE
- 10 Jan 2022 Status changed from recruiting to completed.
- 11 Nov 2021 This trial has been completed in Poland, according to European Clinical Trials Database record.
- 08 Apr 2021 Planned End Date changed from 31 Dec 2020 to 31 Dec 2021.